The Global Light/Laser Ablation Market is mainly driven by increasing aging population with higher risk of chronic diseases and increasing procedures through minimal invasive surgery and it was valued at $1183 million in 2013 and is expected to reach $1859 million by 2018. The Excimer Laser market is the largest segment of the Light/Laser Ablation Market.
The Light/Laser ablation devices consist of two types of lasers namely- cold lasers and excimer lasers. These are the most commonly used for ablation procedures in ophthalmology in vision correction and to a certain extent for epidermal treatment. It also shows considerable success in the ablation of cervix, uterus, varicose vein and prostate.
In terms of volume, the Americas contributed the largest volume of sales for the global Light/Laser ablation market.
Older population is growing in the mature markets such as Japan, U.S. and in the western European countries. Currently, one quarter of the Japanese population is aged 65 and above. Currently, in the U.S., 40 million people are aged 65 and above and it is expected that by 2050 this number will rise to 89 million. Diseases such as cancer, cardiovascular disorders, gynecological, and orthopedic problems are on the rise. As the number of patient population will increase it will lead to increase in the procedural volume of minimally invasive surgeries, ultimately giving rise to increased demand for Light/Laser ablation devices.
Emerging markets such as India, China, and Brazil have undergone significant economic development over the past decade. This development has also led to an increase in healthcare availability in these countries. Also, as these countries have relatively modest GDP per capita levels and highly variable healthcare systems, the need for inexpensive light ablation devices is emerging as an important factor. It has provided an opportunity for ablation devices companies, to have an established and growing market in these countries. European market is challenging, as it is a heterogeneous region in terms of regulatory and reimbursement approaches, with every country having its own unique characteristics. Aging Japanese population, which is at a higher risk of developing chronic diseases such as cancer and cardiac disorders, will ultimately lead to growth in procedure volume of Light/Laser ablation devices in the future.
The report also provides an extensive competitive landscaping of companies operating in Light/Laser market. The key players in light ablation market operating especially in the optical correction Light/Laser ablation are Alcon, Abbott, Carl Zeiss followed by others.
Segment and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.
The Market data enables you to customize the MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:
- Usage pattern (in-depth trend analysis) of products (Segment wise)
- Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level
- End-user Adoption rate analysis of the products (Segment wise and Country wise)
- Comprehensive coverage of Product approvals, Pipeline products and Product recalls
- Country specific Prevalence of cancer, cardiovascular disorders, gynecological, and orthopedic disorders.
- Country specific Patient pool of cancer, cardiovascular disorders, gynecological, and orthopedic disorders.
- Disease progression (Pattern analysis)
Surgeons/Physicians Perception Analysis
- Fast turn-around analysis of Surgeons response to market events and trends
- Surgeons opinion about products from different companies
- Surgeons qualitative inputs on epidemiology date
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
Americas Light/Laser Ablation
The American Light/Laser Ablation Market, was pegged at $347 million in 2013 and expected to be $527 million by 2018. The Excimer Laser market is the largest segment of Light/Laser Ablation Market. The key players operating in the optical correction Light/Laser ablation are Alcon, Abbott, Carl Zeiss followed by others.
Asia-Pacific Light/Laser Ablation
The Asia-Pacific Light/Laser Ablation Market was pegged at $192 million in 2013 and expected to be $330 million by 2018. The Excimer Laser market is the largest segment of Light/Laser Ablation Market. The key players operating in the optical correction Light/Laser ablation are Alcon, Abbott, Carl Zeiss followed by others.
European Light/Laser Ablation
The European Light/Laser Ablation Market was pegged at $298 million in 2013 and expected to be $450 million by 2018. The Excimer Laser market is the largest segment of Light/Laser Ablation Market. The key players operating in the optical correction Light/Laser ablation are Alcon, Abbott, Carl Zeiss followed by others.